Medicilon(SH:688202) Xin Lang Cai Jing·2025-11-26 02:11Group 1 - The core viewpoint of the news is that Shanghai Medicilon Inc. has seen a stock price increase of 5.04%, reaching 59.77 CNY per share, with a total market capitalization of 8.03 billion CNY [1] - Medicilon was established on February 2, 2004, and went public on November 5, 2019, providing comprehensive new drug research and development services for pharmaceutical companies and other new drug research institutions [1] - The company's main business revenue composition includes 50.34% from preclinical research, 49.64% from drug discovery and pharmaceutical research, and 0.01% from other supplementary services [1] Group 2 - From the perspective of fund holdings, Wan Jia Fund has one fund heavily invested in Medicilon, specifically the Wan Jia National Index 2000 ETF, which held 99,500 shares, accounting for 0.54% of the fund's net value [2] - The Wan Jia National Index 2000 ETF was established on June 29, 2022, with a latest scale of 1.286 billion CNY and has achieved a year-to-date return of 26.92% [2] - The fund manager, Yang Kun, has a total asset scale of 13.868 billion CNY, with the best fund return during his tenure being 81.38% and the worst being -32.3% [2]